Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man.
Ten healthy male volunteers were given trimethadione (TMO) 4 mg/kg and antipyrine (AP) 500 mg alone or concomitantly to determine whether the metabolism of the drugs was mediated by the same or closely related forms of cytochrome P-450. Whether administered alone or together the clearance (CL) and half-life (t 1/2) of TMO and AP were the same, and there was a good correlation between the CL and t 1/2 of TMO and AP (alone r = 0.755 and 0.623, respectively; coadministered r = 0.771 and 0.503, respectively). Excretion of AP and its main metabolite and the clearance for production of AP metabolites after AP was administered alone were not significantly different when TMO and AP were taken together. When the two drugs were administered alone or coadministered, the correlation between the CL of TMO and the excretion of 3-hydroxymethyl-3-norantipyrine (NORA) was close (alone r = 0.734, coadministered r = 0.749). The correlation between the CL of TMO and CLm of NORA when TMO and AP were given alone or concomitantly was 0.762 and 0.772, respectively. The findings suggest that TMO metabolism and the formation of NORA in healthy subjects are mediated by a closely related form(s) of the cytochrome P-450 system.
Tanaka
E
E
Institute of Community Medicine, University of Tsukuba, Japan.
Nakamura
K
K
D000328:Adult; D000983:Antipyrine / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics; D001711:Biotransformation; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D008297:Male; D010080:Oxazoles / Q000378:metabolism*; D014293:Trimethadione / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics
D010080:Oxazoles; D003577:Cytochrome P-450 Enzyme System; D014293:Trimethadione; D000983:Antipyrine